← Eichor
Study identifier: NCT06763653 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ultra Low Frequency Neuromodulation for Nociceptive Chronic Low Back Pain

Condition: Nociceptive Pain · Axial Back Pain  ·  Sponsor: Presidio Medical, Inc

PhaseNA
Planned participants303
Who can joinAll sexes, 22 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if Ultra Low Frequency (ULF) neuromodulation works to treat nociceptive chronic low back pain in adults. It will also evaluate the safety of ULF therapy. The main questions it aims to answer are: * Does ULF neuromodulation reduce chronic low back pain? * What, if any, unexpected medical problems do participants experience when treated with ULF neuromodulation? Researchers will compare ULF therapy to conventional treatments for chronic low back pain. Participants will: * Be randomly assigned to either the study device or to conventional medical treatments * Undergo standard surgical procedures to place the study device if assigned to the device arm * Attend regular clinic visits over 24 months for checkups and data collection

This description comes directly from the study's public registry record.

Talk to the study team

Valerie Cimmarusti  ·  +1 (626) 353-8667  ·  vcimmarusti@presidiomedical.com

Always discuss trial participation with your own doctor first.

Locations (3)

The International Spine CentreNorwood, South Australia, AustraliaRecruiting
CerCare Pty LtdWayville, South Australia, AustraliaRecruiting
Monash House Research CentreClayton, Victoria, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06763653